Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Better cardiovascular health among middle-aged Black women linked to less decline in cognition

Better cardiovascular health among middle-aged Black women linked to less decline in cognition

Neurons re-entering cell cycle succumb to senescence in neurodegenerative diseases

Neurons re-entering cell cycle succumb to senescence in neurodegenerative diseases

$4.8 million grant supports research on TDP-43 misfolding in neurodegenerative diseases

$4.8 million grant supports research on TDP-43 misfolding in neurodegenerative diseases

Bursts of beta rhythms control cognition in the brain

Bursts of beta rhythms control cognition in the brain

State-of-the art imaging reveals how lipid metabolism is changed in Alzheimer's disease

State-of-the art imaging reveals how lipid metabolism is changed in Alzheimer's disease

New tool hunts for Alzheimer's clues in gut microbiome

New tool hunts for Alzheimer's clues in gut microbiome

Large-scale study identifies new approach to early Alzheimer's detection

Large-scale study identifies new approach to early Alzheimer's detection

Study identifies potential strategy to diminish the devastating impacts of traumatic brain injuries

Study identifies potential strategy to diminish the devastating impacts of traumatic brain injuries

New platform can deliver gene therapy precisely to specific areas of the brain

New platform can deliver gene therapy precisely to specific areas of the brain

Exploring the benefits of blueberries: Studies link extract to reduced cognitive aging

Exploring the benefits of blueberries: Studies link extract to reduced cognitive aging

Salk scientists explain how CBN protects the brain against aging and neurodegeneration

Salk scientists explain how CBN protects the brain against aging and neurodegeneration

Universities collaborate on $15 million project investigating inflammation's role in cardiac and brain diseases

Universities collaborate on $15 million project investigating inflammation's role in cardiac and brain diseases

Study reveals neuronal mechanisms behind working memory

Study reveals neuronal mechanisms behind working memory

Study reveals accelerated progression of Alzheimer's in people with Down syndrome

Study reveals accelerated progression of Alzheimer's in people with Down syndrome

Junk food-filled diet in teens may disrupt brains' memory ability for a long time

Junk food-filled diet in teens may disrupt brains' memory ability for a long time

Common HIV drugs linked to reduced Alzheimer's disease risk

Common HIV drugs linked to reduced Alzheimer's disease risk

Study unlocks genetic secrets in APOEε4 carriers that could defend against Alzheimer's

Study unlocks genetic secrets in APOEε4 carriers that could defend against Alzheimer's

Mayo Clinic study offers insights into lucid episodes in dementia

Mayo Clinic study offers insights into lucid episodes in dementia

Geraniol alleviates cognitive decline in D-galactose-induced aging mice

Geraniol alleviates cognitive decline in D-galactose-induced aging mice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.